Your browser doesn't support javascript.
loading
The evolution of the GALactose utilization pathway in budding yeasts.
Harrison, Marie-Claire; LaBella, Abigail L; Hittinger, Chris Todd; Rokas, Antonis.
Afiliação
  • Harrison MC; Department of Biological Sciences, Vanderbilt University, Nashville, TN, USA.
  • LaBella AL; Department of Biological Sciences, Vanderbilt University, Nashville, TN, USA.
  • Hittinger CT; Laboratory of Genetics, DOE Great Lakes Bioenergy Research Center, Wisconsin Energy Institute, Center for Genomic Science Innovation, J.F. Crow Institute for the Study of Evolution, University of Wisconsin-Madison, Madison, WI, USA. Electronic address: cthittinger@wisc.edu.
  • Rokas A; Department of Biological Sciences, Vanderbilt University, Nashville, TN, USA. Electronic address: antonis.rokas@vanderbilt.edu.
Trends Genet ; 38(1): 97-106, 2022 01.
Article em En | MEDLINE | ID: mdl-34538504
The Leloir galactose utilization or GAL pathway of budding yeasts, including that of the baker's yeast Saccharomyces cerevisiae and the opportunistic human pathogen Candida albicans, breaks down the sugar galactose for energy and biomass production. The GAL pathway has long served as a model system for understanding how eukaryotic metabolic pathways, including their modes of regulation, evolve. More recently, the physical linkage of the structural genes GAL1, GAL7, and GAL10 in diverse budding yeast genomes has been used as a model for understanding the evolution of gene clustering. In this review, we summarize exciting recent work on three different aspects of this iconic pathway's evolution: gene cluster organization, GAL gene regulation, and the population genetics of the GAL pathway.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article